EUVIMEDEUVIMED entdecken
Crossref

Lapachol inhibits the growth of lung cancer by reversing M2-like macrophage polarization via activating NF-κB signaling pathway

Zhengzheng Zhang, Luyao Bai, Chunhua Lu, Xintong Li, Yang Wu, Xiaochun Zhang, Yuemao Shen

Cellular Signalling · 2023-12 · 112 · 110902

DOI: 10.1016/j.cellsig.2023.110902 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2023-12. Verfasst von Zhengzheng Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jina…. Hauptthemen laut MEDLINE: NF-kappa B, Lung Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Resetting tumor-associated macrophages (TAMs) is a promising strategy to ameliorate the immunosuppressive tumor microenvironment (TME) and improve innate and adaptive antitumor immunity. Lapachol, a naturally occurring 1,4-naphthoquinone, exhibits various pharmacological activities including antitumor, anti-leishmanial, antimalarial and antiseptic. In this study, we investigated the relevance of macrophage polarization and the antitumor effect of lapachol in Lewis lung cancer (LLC) both in vitro and in vivo. This study demonstrated that lapachol significantly reversed the polarization of M2-like macrophages thus that were endowed with the ability to kill LLC cells by activating NF-κB signaling pathway. Furthermore, lapachol effectively suppressed tumor growth in C57BL/6 mice bearing lung tumors by reducing the proportion of M2-like macrophages. Overall, our findings clearly illustrated that lapachol could reverse the polarization of M2-like macrophages to improve the immunosuppressive tumor microenvironment, and had the potential to be developed as an immunomodulatory antitumor agent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BLung NeoplasmsMiceAnimalsMice, Inbred C57BLCell Line, TumorSignal TransductionMacrophagesTumor MicroenvironmentNaphthoquinones

Stichwörter der Autor:innen

AntitumorLapacholLewis lung cancerNF-κBTumor-associated macrophage

Substanzen

NF-kappa BlapacholNaphthoquinones

Autor:innen und Institutionen

  • Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
  • Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, China. Electronic address: ahua0966@sdu.edu.cn.
  • Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, China. Electronic address: yshen@sdu.edu.cn.

Zitieren

APA

Zhang, Z., Bai, L., Lu, C., Li, X., Wu, Y., Zhang, X., & Shen, Y. (2023). Lapachol inhibits the growth of lung cancer by reversing M2-like macrophage polarization via activating NF-κB signaling pathway. Cellular Signalling, 112, 110902. https://doi.org/10.1016/j.cellsig.2023.110902

Vancouver

Zhang Z, Bai L, Lu C, Li X, Wu Y, Zhang X, et al. Lapachol inhibits the growth of lung cancer by reversing M2-like macrophage polarization via activating NF-κB signaling pathway. Cellular Signalling. 2023;112:110902. doi:10.1016/j.cellsig.2023.110902

BibTeX
@article{Zhang2023,
  author = {Zhang, Zhengzheng and Bai, Luyao and Lu, Chunhua and Li, Xintong and Wu, Yang and Zhang, Xiaochun and Shen, Yuemao},
  title = {Lapachol inhibits the growth of lung cancer by reversing M2-like macrophage polarization via activating NF-κB signaling pathway},
  journal = {Cellular Signalling},
  year = {2023},
  volume = {112},
  pages = {110902},
  doi = {10.1016/j.cellsig.2023.110902}
}
Kostenlos starten →